BRBI BR Partners S.A.

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Cash flows from operating activities
Income from Discontinued Operations $506k $5.7m
Depreciation and amortization $129.6m $127.9m $125.2m $120.9m $116.8m $104.6m $58.8m $6.7m $7.5m $10.8m
Depreciation Expense $76k $57k $52k
Deferred taxes ($6.1m) $7.5m $31.2m
Impairment losses $1.5m $14.4m $13.1m
Goodwill Impairment $5k
Equity in losses and impairment charges for investments in unconsolidated affiliates $2.6m $6.3m $18.1m $29.9m
Income Tax Expense $15k
Interest Expense $339k $349k $373k $382k $393k $64.9m $59.2m $67.5m $73.6m $73.9m
Loss on debt extinguishment $292k $1.6m $0 $0 $109k $16.0m $0 $0 $215k $0
Profit $155.1m $193.7m $175.1m
Provision for contingencies $143k $162k ($326k)
Interest - subordinated financial bills $165k $25.5m $94.8m
Total $104.2m $202.5m $285.3m
Financial assets at fair value through profit or loss ($1.4b) ($1.6b) ($2.4b)
Derivative financial instruments $342.9m ($943.2m) $75.0m
- Loans $36.4m ($161.2m) $148.4m
- Other financial assets at amortized cost ($961.4m) ($231.0m) $290.7m
Financial assets at fair value through other comprehensive income ($409.4m) ($1.2b) ($930.2m)
Other assets ($5.2m) $42k $386k
Amounts payable – suppliers $1.4m $11.3m ($4.8m)
- Repurchase agreements $697.3m $2.4b $1.9b
- Client deposits $760.4m $570.1m ($989.5m)
- Other financial liabilities $939.6m $195.3m ($357.6m)
Financial liabilities at fair value through profit or loss $33.2m
Taxes payable $59.5m $14.4m $32.6m
Other amounts payable $7.1m ($568k) ($35.0m)
Acquisition of intangible assets ($5.8m)
Cash (used in) investing activities ($8.0m) ($2.8m) ($572k)
Lease liabilities ($2.4m) ($6.4m) ($8.2m)
Issuance of subordinated financial bills $72.6m $372.9m $194.4m
Payment of coupons financial bills ($7.2m) ($42.6m)
Cash generated by (used in) in financing activities ($68.4m) $154.6m ($51.6m)
Interest received $826.4m $1.2b $1.4b
Profit or Loss ($172k) ($246k) ($326k) ($298k) ($2.9m)
Stock-based compensation $39k $4k $300k $528k
Non-Operating Income (Expense) $173k
Change in fair value of investment ($175k)
Prepaid expenses and other current assets $1k ($5k) $8k ($4k) $4k ($4k) ($9k)
Receivables $44k
Accounts payable and accrued expenses ($7k) ($764k) $1k $8k ($41k) $4k $1.0m
Deferred revenue ($1.5m) $2.4m $6.6m ($69k) $15.9m ($281k) $8k ($4.8m)
Related party payable ($5k) ($12k)
Cash paid for website costs ($2k)
Cash distribution to stockholder ($215.5m) ($216.6m) ($147.2m) ($147.9m) ($130.2m) ($5.1m) ($81.7m) ($82.4m) ($775) ($84.2m)
Cash paid for stock issuance costs in business combinations ($3k)
Stock Repurchases (Issuances) $189k $400k $193k
Net change in cash $5k ($53k) $93k $52k $5.4m ($5.4m) $118k ($239k) $46k ($57k)
Cash at beginning of period $80k $27k $246k $7k $50k
Cancellation of liability-classified warrants – Related party $167k
Forgiveness of debt - related party $14k
Net loss $33k ($509k) ($202k) $68.6m $60.8m ($326k) ($287k) ($8.5m) ($298k) $106.6m
Stock-based compensation – related party $23k $8.1m
Repayment of note payable ($40k)
Prepaid expenses $1k $1k ($4k) $4k
Cash at beginning of year $120k $172k $5.5m $128k $246k $14.1m $20.5m
Accounts receivable $143k ($23k) ($108k) ($281k) $605k $63k ($7.1m) $15.1m $1.3m ($4.1m)
Customer advance ($271k) $45k ($69k)
Proceeds from Sale of PP&E $88k $2.1m
Sale-leaseback financing obligation ($2.2m)
Decrease in other assets $47k
Cash distribution to stockholders ($5.1m)
Repayment of related party notes payable ($5k) ($140k)
Accounts receivable-other ($45k) ($18k) ($229k) $183k $185k
Change in Deferred Revenue ($30k) ($13k)
Provision for inventory reserve ($43k) $54k ($30k)
(Increase) decrease in inventories $90k $13k ($78k) $14.4m ($1.6m) ($14.8m) ($4.8m) $5.1m $6.6m ($14.1m)
Increase (decrease) in accounts payable ($19k) $174k $94k
Change in Accrued Liabilities ($155k) $73k $13k
Increase (decrease) in customer advance ($35k) ($35k) $288k
Repayment of promissory note ($50k) ($5k)
Cash at end of period $75k $27k $120k
Repayment of capital lease obligation ($7k)
Purchase of equipment on capital lease ($38.4m) ($28.2m) ($32.9m) ($35.0m) ($32.5m) ($29.9m) ($44.4m) ($44.9m) ($59.4m) ($72.0m)
Compensation costs recognized under Restricted Unit Plans $8.2m $10.5m $9.2m $10.1m $11.3m $8.3m $8.2m $7.8m
Pension settlement charge $2.0m $6.1m $0 $0 $1.1m $958k $840k $0 $638k $528k
Other, net $9.2m $9.3m $1.1m $1.7m $923k $3.1m $357k $1.5m $4.1m $4.5m
Other current and noncurrent assets $2.0m ($9.6m) ($5.4m) $8.2m ($9.8m) ($40.0m) ($5.4m) $6.1m ($2.8m) $18.6m
Accounts payable ($1.9m) $7.1m $809k ($7.0m) $1.5m $6.8m ($4.3m) ($206k) $1.1m $939k
Accrued employment and benefit costs ($12.7m) $10.9m $5.0m $2.3m $526k $5.6m $2.3m $1.5m ($5.2m) $6.3m
Accrued insurance $2.6m $8.9m $2.0m ($3.3m) $5.7m ($6.8m) ($2.1m) ($2.9m) ($3.1m) ($1.4m)
Contributions to defined benefit pension plan ($715k) ($11.5m) ($4.8m) ($5.3m) ($3.8m) ($6.3m) ($3.3m) ($4.0m) ($4.0m) ($4.0m)
Other current and noncurrent liabilities $12.5m $1.6m $9.3m $1.6m $16.9m $33.1m $15.8m $2.4m ($4.9m) ($32.5m)
Investments in and acquisitions of businesses ($42.9m) $0 ($14.9m) ($19.3m) ($25.6m) ($8.7m) ($56.1m) ($130.1m) ($25.2m) ($59.5m)
Proceeds from sale of business $21.5m $0 $2.8m $0 $0 $0 $850k $0 $0
Proceeds from borrowings under revolving credit facility $100.0m $374.8m $350.1m $370.7m $493.0m $447.0m $386.6m $525.7m $626.0m $459.2m
Repayments of borrowings under revolving credit facility ($100.0m) ($312.2m) ($369.1m) ($400.8m) ($511.9m) ($409.6m) ($429.0m) ($483.3m) ($607.0m) ($461.0m)
Issuance costs associated with long-term borrowings ($2.7m) ($7.1m) $0 $0 ($2.7m) ($10.8m) $0 $0 ($3.7m) $0
Proceeds from the issuance of Common Units under an at-the-market equity program, net of commissions and offering costs $0 $0 $23.5m
Proceeds from long-term borrowings $0 $350.0m $0 $0 $0 $650.0m $0 $0
Repayments of long-term borrowings $0 ($360.9m) $0 $0 $0 ($786.3m) $0 $0
Loss on sale of business ($9.8m) $0 $4.8m $0 $0
Customer deposits and advances $1.2m ($9.1m) ($1.5m)
Repayment of long-term borrowings (includes premium and fees) $0
Cash flows from investing activities
Acquisition of property, plant and equipment for use $6.0m $5.2m $5.9m $5.8m $4.9m $4.5m $5.2m ($2.2m) ($2.8m) ($572k)
Net Cash from Investing Activities ($10k) $150k
Net cash flows (used in) provided by investing activities ($53.9m) ($23.0m) ($10k) $88k ($16k) ($34.1m) ($94.4m) ($170.6m) ($81.6m) ($128.3m)
Cash flows from financing activities
- Debt issued and others $75.0m $842.6m $1.6b
Proceeds from Debt Issuance $150k $40k
Repayments of Debt ($7k)
Common Stock issued for services $139k
Common Stock issued for the acquisition of Bio-Convert $39.0m
Common Stock issued for the acquisition of Orocidin $19.0m
Dividends paid ($139) ($205) ($195)
Deemed dividend $1.4m
Net Cash from Financing Activities $115k $306k $889k
Net cash provided (used) by financing activities ($57k) $150k ($5k) ($5k) $49k ($5.1m) $400k $129k $305k ($66.7m)
Effect of changes in exchange rates on cash and cash equivalents $53.3m $46.1m $39.4m
Effect of Exchange Rate on Cash $665 ($4k) $27k
Increase (decrease) in cash and cash equivalents $156.4m $241.9m ($476.9m)
Net (decrease) increase in cash, cash equivalents and restricted cash $2.4m ($2.7m) $699k $2.7m ($1.7m) $10.0m $6.4m ($8.7m)
Net increase (decrease) in cash and cash equivalents ($115.0m) ($34.6m) $2.4m
Cash and cash equivalents at the beginning of the year $287.2m $575.2m $137.8m
Less: restricted cash $0 $0 $10.6m $17.3m $11.4m
Cash and cash equivalents, end of period $152.3m $37.3m $2.8m $5.2m $2.4m $5.8m $4.1m $3.5m $3.2m $405k
Interest paid $74.3m $76.6m ($657.0m) ($1.4b) ($1.4b)
Income tax and social contribution paid ($58.6m) ($36.2m) ($31.9m)

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.